Historical Stock Price
EXAS historical stock prices picture
EXACT Sciences (EXAS) has the following price history information. Looking back at EXAS historical stock prices for the last five trading days, on April 12, 2024, EXAS opened at $72.92, traded as high as $73.10 and as low as $70.78, and closed at $71.34. Trading volume was a total of 2.43M shares. On April 15, 2024, EXAS opened at $70.57, traded as high as $71.85 and as low as $65.30, and closed at $65.35. Trading volume was a total of 3.06M shares. On April 16, 2024, EXAS opened at $64.85, traded as high as $66.05 and as low as $63.64, and closed at $63.86. Trading volume was a total of 3.47M shares. On April 17, 2024, EXAS opened at $65.62, traded as high as $66.74 and as low as $62.88, and closed at $63.22. Trading volume was a total of 2.52M shares. On April 18, 2024, EXAS opened at $62.79, traded as high as $64.92 and as low as $61.78, and closed at $63.48. Trading volume was a total of 1.60M shares.

EXAS Historical Stock Prices By Date:

EXAS historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into EXACT Sciences shares, starting with a $10,000 purchase of EXAS, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/22/2014
End date: 04/18/2024
Start price/share: $13.16
End price/share: $63.48
Dividends collected/share: $0.00
Total return: 382.37%
Average Annual Total Return: 17.05%
Starting investment: $10,000.00
Ending investment: $48,253.28
Years: 10.00
Date Open High Low Close Volume
04/12/2024 $72.92 $73.10 $70.78 $71.34 2.43M
04/15/2024 $70.57 $71.85 $65.30 $65.35 3.06M
04/16/2024 $64.85 $66.05 $63.64 $63.86 3.47M
04/17/2024 $65.62 $66.74 $62.88 $63.22 2.52M
04/18/2024 $62.79 $64.92 $61.78 $63.48 1.60M
Exact Sciences is a cancer screening and diagnostics company. Co.'s primary screening product, the Cologuard® test, is a non-invasive stool-based DNA screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. Co.'s portfolio of Oncotype tests include: Oncotype DX gene expression tests for breast, prostate and colon cancers; Oncotype DX AR-V7 Nucleus Detect® test, a liquid-based test for advanced stage prostate cancer; and Oncotype MAP™ Pan-Cancer Tissue test (oncomap test), a test delivering tumor profiling to aid therapy selection for patients with metastatic, refractory or recurrent cancer.
Date Close
04/12/2024$71.34
04/15/2024$65.35
04/16/2024$63.86
04/17/2024$63.22
04/18/2024$63.48
EXAS is categorized under the Healthcare sector; below are some other companies in the same sector:

EXEL Historical Stock Prices
EYE Historical Stock Prices
EYEG Historical Stock Prices
EYES Historical Stock Prices
FATE Historical Stock Prices
FCRE Historical Stock Prices
FCSC Historical Stock Prices
FGEN Historical Stock Prices
FLDM Historical Stock Prices
FLGT Historical Stock Prices

Also explore: EXAS shares outstanding history

Email EnvelopeFree EXAS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


EXAS Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.